Terms: = Pancreatic cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
48 results:
1. Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.
Pei F; Tao Z; Lu Q; Fang T; Peng S
World J Surg Oncol; 2024 Apr; 22(1):110. PubMed ID: 38664770
[TBL] [Abstract] [Full Text] [Related]
2. Selective HIF2A Inhibitors in the Management of Clear Cell Renal cancer and Von Hippel-Lindau-Disease-Associated Tumors.
Suárez C; Vieito M; Valdivia A; González M; Carles J
Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
[TBL] [Abstract] [Full Text] [Related]
3. Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cells.
Wang H; Liu Y; Wang Y; Xu T; Xia G; Huang X
Cancer Med; 2023 Jul; 12(14):15277-15288. PubMed ID: 37409635
[TBL] [Abstract] [Full Text] [Related]
4. Evaluating the biological effectiveness of boron neutron capture therapy by using microfluidics-based pancreatic tumor spheroids.
Yu LY; Hsu CH; Li CY; Hong SY; Chen CR; Chen CS
Analyst; 2023 Jun; 148(13):3045-3056. PubMed ID: 37272284
[No Abstract] [Full Text] [Related]
5. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
6. Deubiquitinating enzyme Josephin-2 stabilizes PHGDH to promote a cancer stem cell phenotype in hepatocellular carcinoma.
Wang Y; Li ZX; Wang JG; Li LH; Shen WL; Dang XW
Genes Genomics; 2023 Feb; 45(2):215-224. PubMed ID: 36583817
[TBL] [Abstract] [Full Text] [Related]
7. Prolyl 4-hydroxylase P4HA1 Mediates the Interplay Between Glucose Metabolism and Stemness in pancreatic cancer Cells.
Cao X; Cao Y; Zhao H; Wang P; Zhu Z
Curr Stem Cell Res Ther; 2023; 18(5):712-719. PubMed ID: 36043766
[TBL] [Abstract] [Full Text] [Related]
8. Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[
Ohshima Y; Sasaki I; Watanabe S; Sakashita T; Higashi T; Ishioka NS
Nucl Med Biol; 2022; 112-113():44-51. PubMed ID: 35802985
[TBL] [Abstract] [Full Text] [Related]
9. Counterintuitive production of tumor-suppressive secretomes from oct4- and c-Myc-overexpressing tumor cells and MSCs.
Li K; Sun X; Zha R; Liu S; Feng Y; Sano T; Aryal UK; Sudo A; Li BY; Yokota H
Theranostics; 2022; 12(7):3084-3103. PubMed ID: 35547745
[No Abstract] [Full Text] [Related]
10. 5-fluorouracil suppresses stem cell-like properties by inhibiting p38 in pancreatic cancer cell line PANC-1.
Zhao J; Shi X; Dong C; Liu R; Su L; Cao C
Folia Histochem Cytobiol; 2022; 60(1):55-65. PubMed ID: 35103981
[TBL] [Abstract] [Full Text] [Related]
11. Ethanol exposure of human pancreatic normal ductal epithelial cells induces EMT phenotype and enhances pancreatic cancer development in KC (Pdx1-Cre and LSL-Kras
Yu W; Ma Y; Roy SK; Srivastava R; Shankar S; Srivastava RK
J Cell Mol Med; 2022 Jan; 26(2):399-409. PubMed ID: 34859959
[TBL] [Abstract] [Full Text] [Related]
12. MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas.
Luan Z; Morimoto Y; Fushimi A; Yamashita N; Suo W; Bhattacharya A; Hagiwara M; Jin C; Kufe D
Carcinogenesis; 2022 Feb; 43(1):67-76. PubMed ID: 34657147
[TBL] [Abstract] [Full Text] [Related]
13. Establishment and Characterization of a New pancreatic Ductal Adenocarcinoma Cell Line Capan-26.
Zalyte E; Dedonyte V; Kurlinkus B; Sileikis A; Schemmer P; Valius M
Anticancer Res; 2021 Mar; 41(3):1401-1406. PubMed ID: 33788731
[TBL] [Abstract] [Full Text] [Related]
14. LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation.
Pouraghajan K; Mahdiuni H; Ghobadi S; Khodarahmi R
J Biomol Struct Dyn; 2022 Apr; 40(7):3082-3097. PubMed ID: 33183172
[TBL] [Abstract] [Full Text] [Related]
15. NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant pancreatic cancer Cells by Suppressing HO-1 and ABCG2 Expression.
Kim EJ; Kim YJ; Lee HI; Jeong SH; Nam HJ; Cho JH
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32629871
[TBL] [Abstract] [Full Text] [Related]
16. Apigenin as an anticancer agent.
Imran M; Aslam Gondal T; Atif M; Shahbaz M; Batool Qaisarani T; Hanif Mughal M; Salehi B; Martorell M; Sharifi-Rad J
Phytother Res; 2020 Aug; 34(8):1812-1828. PubMed ID: 32059077
[TBL] [Abstract] [Full Text] [Related]
17. Effects of Fentanyl on pancreatic cancer cell proliferation and cancer stem cell differentiation.
Celik F; Duran T
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):21-25. PubMed ID: 31880513
[TBL] [Abstract] [Full Text] [Related]
18. Direct differentiation of insulin-producing cells from human urine-derived stem cells.
Hwang Y; Cha SH; Hong Y; Jung AR; Jun HS
Int J Med Sci; 2019; 16(12):1668-1676. PubMed ID: 31839754
[TBL] [Abstract] [Full Text] [Related]
19. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications.
Gzil A; Zarębska I; Bursiewicz W; Antosik P; Grzanka D; Szylberg Ł
Mol Biol Rep; 2019 Dec; 46(6):6629-6645. PubMed ID: 31486978
[TBL] [Abstract] [Full Text] [Related]
20. TSPAN8 promotes cancer cell stemness via activation of sonic Hedgehog signaling.
Zhu R; Gires O; Zhu L; Liu J; Li J; Yang H; Ju G; Huang J; Ge W; Chen Y; Lu Z; Wang H
Nat Commun; 2019 Jun; 10(1):2863. PubMed ID: 31253779
[TBL] [Abstract] [Full Text] [Related]
[Next]
